STAT+: GLP-1 drug helped type 1 diabetes patients keep healthy glucose levels and lose weight
Obesity drugs were first approved to treat type 2 diabetes, but there’s a growing movement to test them in type 1 diabetes, too. Research presented Monday at a large diabetes meeting showed some promise for this approach. Patients who took a GLP-1 drug fared better than those in a control group at keeping their blood […]
Significant Weight Loss With CagriSema, But Less Than Hoped
Experts said that the novel combination of a GLP-1 and amylin analogue will help obese patients with and without diabetes improve their health. Medscape Medical News
Experimental drug helps patients lose nearly a quarter of body weight in early trials
An experimental weight-loss medication was shown to help people lose nearly 25% of their body weight in early-stage 1a/2b trials. The drug, amycretin — developed by Novo Nordisk — works by replicating two hunger hormones — amylin, which regulates appetite and creates a feeling of fullness, and glucagon-like peptide 1 (GLP-1), the same hormone that […]
Weekly semaglutide improves blood sugar and weight in adults with type 1 diabetes, clinical trial finds
A new clinical trial found that taking a popular diabetes and weight-loss drug once weekly significantly improves blood sugar and leads to substantial weight loss in adults with type 1 diabetes who use automated insulin delivery systems.
Ozempic Shows Benefit in Type 1 Diabetes Patients With Obesity
(MedPage Today) — CHICAGO — Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a randomized trial showed.
In this 26-week, double-blind trial of 72 adults, 36% who received 1 mg of the…